xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

431

ICAR SINONASAL TUMORS

1447. Su SY, De Almeida JR, Filho FVG, et al. Endoscopic endonasal resection of sinonasal undifferentiated carcinoma: the UPMC experience. J Neurol Surg B Skull Base . 2013;74(Suppl. 1):A009. https://doi.org/10.1055/s-0033-1336143 1448. Yoshida E, Aouad R, Fragoso R, et al. Improved clinical outcomes with multi-modality therapy for sinonasal undif ferentiated carcinoma of the head and neck. Am J Otolaryn gol . 2013;34(6):658-663. https://doi.org/10.1016/j.amjoto.2013. 06.005 1449. Millard R, O’Shea N, Powell H, et al. Combined modality man agement of sinonasal undifferentiated carcinoma. J Neurol Surg B Skull Base . 2013;74(Suppl. 1):A008. https://doi.org/10. 1055/s-0033-1336142 1450. Xu CC, Dziegielewski PT, McGaw WT, Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg . 2013;42:2. https://doi.org/10.1186/1916-0216-42-2 1451. Mourad WF, Hauerstock D, Shourbaji RA, et al. Trimodal ity management of sinonasal undifferentiated carcinoma and review of the literature. Am J Clin Oncol . 2013;36(6):584-588. https://doi.org/10.1097/COC.0b013e31825eb3a5 1452. Lee LN, Gray ST, Curry W, et al. Multimodality treatment out comes of sinonasal undifferentiated carcinoma of the skull base. J Neurol Surg B Skull Base . 2012;73(Suppl. 1):A163. https://doi.org/10.1055/s-0032-1312211 1453. Revenaugh PC, Seth R, Pavlovich JB, Knott PD, Batra PS. Minimally invasive endoscopic resection of sinonasal undif ferentiated carcinoma. Am J Otolaryngol . 2011;32(6):464-469. https://doi.org/10.1016/j.amjoto.2010.09.006 1454. Lin EM, Sparano A, Spalding A, et al. Sinonasal undifferen tiated carcinoma: a 13-year experience at a single institution. Skull Base . 2010;20(2):61-67. https://doi.org/10.1055/s-0029 1236165 1455. Minato H, Kobayashi E, Nakada S, et al. Sinonasal NUT carcinoma: clinicopathological and cytogenetic analysis with autopsy findings. HumPathol . 2018;71:157-165. https://doi.org/ 10.1016/j.humpath.2017.10.011 1456. Chitguppi C, Rabinowitz MR, Johnson J, et al. Loss of SMARCB1 expression confers poor prognosis to sinonasal undifferentiated carcinoma. J Neurol Surg B Skull Base . 2020;81(6):610-619. https://doi.org/10.1055/s-0039-1693659 1457. Allard FD, Bell D, Stelow EB. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma. Cancer Cytopathol . 2018;126(8):567-574. https://doi.org/10.1002/cncy. 22020 1458. Laco J, Chmelařová M, Vošmiková H, et al. SMARCB1/INI1 deficient sinonasal carcinoma shows methylation of RASSF1 gene: a clinicopathological, immunohisto chemical and molecular genetic study of a recently described entity. Pathol Res Pract . 2017;213(2):133-142. https://doi.org/10.1016/j.prp.2016.10.012 1459. Bell D. Sinonasal neuroendocrine neoplasms: current chal lenges and advances in diagnosis and treatment, with a focus on olfactory neuroblastoma. Head Neck Pathol . 2018;12(1):22 30. https://doi.org/10.1007/s12105-018-0887-5 1460. Mitchell EH, Diaz A, Yilmaz T, et al. Multimodality treat ment for sinonasal neuroendocrine carcinoma. Head Neck . 2012;34(10):1372-1376. https://doi.org/10.1002/hed.21940

Pathol . 2019;83:59-67. https://doi.org/10.1016/j.humpath.2018. 08.008 1433. Agaimy A, Jain D, Uddin N, Rooper LM, Bishop JA. SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies. Am J Surg Pathol . 2020;44(5):703-710. https:// doi.org/10.1097/PAS.0000000000001428 1434. Mittal N, Bal M, Rane S, Patil A. Sinonasal teratocarcinosar coma: a single institution clinic-pathological study. LabInvest . 2019;99(Suppl. 1):30. 1435. Franchi A. Sinonasal tumor pathology: what’s new? Patholog ica . 2017;109(1):9-13. 1436. Ayyanar P, Mishra P, Preetam C, Adhya AK. SMARCB1/INI1 deficient sino-nasal carcinoma: extending the histomorpho logical features. Head Neck Pathol . 2021;15(2):555-565. https:// doi.org/10.1007/s12105-020-01246-9 1437. Shatzkes DR, Ginsberg LE, Wong M, et al. Imaging appear ance of SMARCB1 (INI1)-deficient sinonasal carcinoma: a newly described sinonasal malignancy. Am J Neuroradiol . 2016;37(10):1925-1929. https://doi.org/10.3174/ajnr.A4841 1438. Agaimy A, Bishop JA. SWI/SNF-deficient head and neck neo plasms: an overview. Semin Diagn Pathol . 2021;38(3):175-182. https://doi.org/10.1053/j.semdp.2021.02.002 1439. Chitguppi C, Berman E, Molligan J, et al. Can INI 1 (SMARCB1) gene determine the survival outcomes in sinonasal undifferentiated carcinoma? J Neurol Surg B Skull Base . 2019;80(Suppl. 1):S1-S244. https://doi.org/10.1055/ s-0039-1679579 1440. Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI 1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol . 2014;38(9):1282-1289. https://doi.org/10.1097/PAS. 0000000000000285 1441. Reiersen DA, Pahilan ME, Devaiah AK. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg . 2012;147(1):7-14. https://doi.org/ 10.1177/0194599812440932 1442. Chamberlain M, Rodriquez C, Liao J. Sinonasal undiffer entiated carcinoma (SNUC): incidence of CNS involvement. Neuro-Oncol . 2016;18(Suppl. 6):vi162. https://doi.org/10.1093/ neuonc/now212.674 1443. Bhasker S, Mallick S, Benson R, Bhanuprasad V, Sharma A, Thakar A. A multimodality approach to sinonasal undifferen tiated carcinoma: a single institute experience. J Laryngol Otol . 2017;131(1):19-25. 1444. Gray ST, Herr MW, Sethi RK, et al. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head Neck . 2015;37(3):366-374. https://doi.org/10.1002/hed. 23606 1445. Liao JJ, Jewell P, Parvathaneni U, Laramore G, Polissar N, Wong W. Management and long-term outcomes of sinonasal undifferentiated carcinoma: twenty-year experience at a sin gle institution. Int J Radiat Oncol Biol Phys . 2014;90(1):S544 S545. 1446. Christopherson KM, Werning JW, Malyapa RS, Morris CG, Mendenhall WM. Radiation therapy for sinonasal undifferen tiated carcinoma. Int J Radiat Oncol Biol Phys . 2013;87(2):S456. https://doi.org/10.1016/j.ijrobp.2013.06.1204